Home
Clinical Resources Search
PQI: Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

Download PQI pdf

Last Updated: August 3, 2025

By: Amir Ali, PharmD, BCOP

About this PQI

The document outlines detailed clinical considerations, dosing schedules, and adverse effect management strategies for elranatamab administration, as well as patient-centered activities and guidelines for healthcare providers.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease

PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer

PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer

PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E9: Keep Saying Yes: Living, Advocating, and Finding Purpose with Cancer

S11 E10: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms

S11 E8: The Future of Oncology

S11 E7: Your Health Story in One Place

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Melphalan Conditioning for Autologous Transplant

Talquetamab, Pomalidomide and Daratumumab/Hyaluronidase

Talquetamab and Daratumumab/Hyaluronidase

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System

Isatuximab-irfc (SARCLISA ESCENA) with the CirCLIQ On-Body Delivery System: Treatment Discussion Guide

Melphalan Conditioning for Autologous Transplant

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

Up Close with Elranatamab

Treatment Support Kit: Elranatamab

Elranatamab

Up Close with Elranatamab

Elranatamab

Elacestrant

PQI: Elacestrant (Orserdu)

PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease

S11 E9: Keep Saying Yes: Living, Advocating, and Finding Purpose with Cancer

Rusfertide (Mimrylo)

Lirafugratinib (Lyrfigtu)